Literature DB >> 27114438

Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.

Jeffrey S Monette1, Patrick M Hutchins1, Graziella E Ronsein1, Jake Wimberger1, Angela D Irwin1, Chongren Tang1, Jaskanwal D Sara1, Baohai Shao1, Tomas Vaisar1, Amir Lerman1, Jay W Heinecke2.   

Abstract

RATIONALE: Coronary endothelial dysfunction (ED)-an early marker of atherosclerosis-increases the risk of cardiovascular events.
OBJECTIVE: We tested the hypothesis that cholesterol efflux capacity and high-density lipoprotein (HDL) particle concentration predict coronary ED better than HDL-cholesterol (HDL-C). METHODS AND
RESULTS: We studied 80 subjects with nonobstructive (<30% stenosis) coronary artery disease. ED was defined as <50% change in coronary blood flow in response to intracoronary infusions of acetylcholine during diagnostic coronary angiography. Cholesterol efflux capacity and HDL particle concentration (HDL-PIMA) were assessed with validated assays. Cholesterol efflux capacity and HDL-PIMA were both strong, inverse predictors of ED (P<0.001 and 0.005, respectively). In contrast, HDL-C and other traditional lipid risk factors did not differ significantly between control and ED subjects. Large HDL particles were markedly decreased in ED subjects (33%; P=0.005). After correction for HDL-C, both efflux capacity and HDL-PIMA remained significant predictors of ED status. HDL-PIMA explained cholesterol efflux capacity more effectively than HDL-C (r=0.54 and 0.36, respectively). The efflux capacities of isolated HDL and serum HDL correlated strongly (r=0.49).
CONCLUSIONS: Cholesterol efflux capacity and HDL-PIMA are reduced in subjects with coronary ED, independently of HDL-C. Alterations in HDL-PIMA and HDL itself account for a much larger fraction of the variation in cholesterol efflux capacity than does HDL-C. A selective decrease in large HDL particles may contribute to impaired cholesterol efflux capacity in ED subjects. These observations support a role for HDL size, concentration, and function as markers-and perhaps mediators-of coronary atherosclerosis in humans.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  apolipoproteins; atherosclerosis; cardiovascular diseases; cholesterol; lipoproteins

Mesh:

Substances:

Year:  2016        PMID: 27114438      PMCID: PMC4920704          DOI: 10.1161/CIRCRESAHA.116.308357

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  47 in total

Review 1.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 3.  Metabolic and functional relevance of HDL subspecies.

Authors:  Bela F Asztalos; Mariko Tani; Ernst J Schaefer
Journal:  Curr Opin Lipidol       Date:  2011-06       Impact factor: 4.776

4.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

5.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

6.  Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.

Authors:  Martin Reriani; Eugenia Raichlin; Abhiram Prasad; Verghese Mathew; Geralyn M Pumper; Rebecca E Nelson; Ryan Lennon; Charanjit Rihal; Lilach O Lerman; Amir Lerman
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

7.  ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.

Authors:  Andrew J Murphy; Mani Akhtari; Sonia Tolani; Tamara Pagler; Nora Bijl; Chao-Ling Kuo; Mi Wang; Marie Sanson; Sandra Abramowicz; Carrie Welch; Andrea E Bochem; Jan Albert Kuivenhoven; Laurent Yvan-Charvet; Alan R Tall
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

8.  Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.

Authors:  Peter Ong; Anastasios Athanasiadis; Gabor Borgulya; Ismail Vokshi; Rachel Bastiaenen; Sebastian Kubik; Stephan Hill; Tim Schäufele; Heiko Mahrholdt; Juan Carlos Kaski; Udo Sechtem
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

9.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.

Authors:  Koji Sato; Koichi Kaikita; Naoki Nakayama; Eiji Horio; Hiromi Yoshimura; Takamichi Ono; Keisuke Ohba; Kenichi Tsujita; Sunao Kojima; Shinji Tayama; Seiji Hokimoto; Kunihiko Matsui; Seigo Sugiyama; Hiroshige Yamabe; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2013-07-15       Impact factor: 5.501

View more
  27 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

3.  Urinary apolipoprotein AI in children with kidney disease.

Authors:  Amanda J Clark; Kathy Jabs; Tracy E Hunley; Deborah P Jones; Rene G VanDeVoorde; Carl Anderson; Liping Du; Jianyong Zhong; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2019-06-23       Impact factor: 3.714

4.  HDL in Morbidity and Mortality: A 40+ Year Perspective.

Authors:  Alan R Tall
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

Review 5.  Inflammation, remodeling, and other factors affecting HDL cholesterol efflux.

Authors:  Graziella E Ronsein; Tomáš Vaisar
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

Review 6.  HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors:  C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal:  Ann Med       Date:  2019 Nov - Dec       Impact factor: 4.709

7.  High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.

Authors:  Tomas Vaisar; Jenny E Kanter; Jake Wimberger; Angela D Irwin; John Gauthier; Emily Wolfson; Vanessa Bahnam; I-Hsien Wu; Hetal Shah; Hillary A Keenan; Carla J Greenbaum; George L King; Jay W Heinecke; Karin E Bornfeldt
Journal:  Diabetes Care       Date:  2019-10-09       Impact factor: 19.112

8.  High-Density Lipoproteins, Endothelial Function, and Mendelian Randomization.

Authors:  Marit Westerterp; Nan Wang; Alan R Tall
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

9.  Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.

Authors:  Marios K Georgakis; Rainer Malik; Christopher D Anderson; Klaus G Parhofer; Jemma C Hopewell; Martin Dichgans
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

10.  Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.

Authors:  Sara Fernández-Castillejo; Laura Rubió; Álvaro Hernáez; Úrsula Catalán; Anna Pedret; Rosa-M Valls; Juana I Mosele; Maria-Isabel Covas; Alan T Remaley; Olga Castañer; Maria-José Motilva; Rosa Solá
Journal:  Mol Nutr Food Res       Date:  2017-10-26       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.